Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

Olaf Merkel1, Daniela Asslaber, Josefina D Piñón

  • 1Laboratory for Immunological and Molecular Cancer Research, IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology of the Paracelsus Medical University Salzburg, Salzburg, Austria. o.merkel@salk.at

Insights

MicroRNA-34a (miR-34a) is elevated in chronic lymphocytic leukemia (CLL) and linked to shorter treatment times. Its apoptosis-inducing effect in CLL cells depends on the p53 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chronic lymphocytic leukemia (CLL) incidence is 4/100,000, with deregulated microRNA (miRNA) expression noted.
  • MicroRNAs are small, non-coding RNAs regulating protein expression by targeting 3'-UTR regions.
  • The miR-34 family, induced by p53, mediates tumor suppressor functions like apoptosis and cell cycle arrest.

Purpose of the Study:

  • Investigate the role of miR-34a in CLL.
  • Determine the relationship between miR-34a expression, SNP309, and treatment time in CLL.
  • Assess the functional impact of miR-34a reintroduction and p53 pathway integrity in CLL cells.

Main Methods:

  • Analysis of miR-34a expression in a TCL1-mouse model of CLL and human CLL samples.
  • Correlation of miR-34a expression with SNP309 in the MDM2 gene promoter.
  • Assessment of miR-34a's effect on apoptosis in CLL cells and p53-knockdown HCT-116 cells.

Main Results:

  • miR-34a is significantly increased in both mouse and human CLL.
  • miR-34a expression is linked to SNP309 and inversely correlated with time to treatment in CLL.
  • Reintroduction of miR-34a induces apoptosis in CLL cells, dependent on an intact p53 pathway.

Conclusions:

  • miR-34a is a key player in CLL pathogenesis.
  • miR-34a expression levels and their dependence on p53 activity can serve as prognostic markers in CLL.
  • miR-34a is proposed as a marker for p53 pathway activity in CLL.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...